Casa Espirita Terra de Ismael   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Jardinópolis Brazil (1996)

Organization Overview

First Clinical Trial
2006
NCT01259947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Casa Espirita Terra de Ismael | Fabio Carmona

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Dyspepsia (Phase 2)

Eczema (Phase 4)

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 11